Back

Statin-free PCSK9 inhibitor therapy versus high-intensity atorvastatin for primary prevention: a target trial emulation study

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lipid lowering (3) Drug therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Chien-Yi Hsu

Taipei Medical University Hospital, Taipei (Taiwan)

5 More presentations in this session

Presentation thumbnail
Improving LDL-C goal attainment: real-world outcomes and the impact of guideline optimization
Doctor R. Rached (DK)
Abstract Slides
Presentation thumbnail
Achievement of LDL‑C targets in clinical practice in Spain: a comparison between Observatory II and Observatory I
Doctor J. Cosin Sales (Valencia, ES)
Abstract Slides
Presentation thumbnail
Evolocumab for high cardiovascular risk patients without previous stroke: a network meta-analysis of randomized controlled trials
Mr S. Phutinart (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Suboptimal LDL cholesterol target achievement in cardiac ATTR amyloidosis despite disease-modifying therapy
Doctor M. Pollak (Berlin, DE)
Abstract Slides
Presentation thumbnail
Lipid-lowering therapy use and LDL-C goal achievement in patients with hypercholesterolaemia or mixed dyslipidaemia in Hong Kong: findings from a retrospective database study
Professor B. Yan (Hong Kong, CN)
Abstract Slides

Access the full session

Session thumbnail
Lipid lowering (3)

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study
1 September 2025
thumbnail
Practice Tools
How to manage blood cholesterol in primary and secondary prevention
16 May 2019
thumbnail
Congress Presentation
High-dose statins are associated with increased aortic valve calcium load in patients with severe stenosis
25 April 2024
thumbnail
Congress Presentation
Statins for venous thromboembolism prevention: old dog, new tricks
1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources